198 related articles for article (PubMed ID: 24080422)
1. Low-molecular-mass secretome profiling identifies C-C motif chemokine 5 as a potential plasma biomarker and therapeutic target for nasopharyngeal carcinoma.
Lin SJ; Chang KP; Hsu CW; Chi LM; Chien KY; Liang Y; Tsai MH; Lin YT; Yu JS
J Proteomics; 2013 Dec; 94():186-201. PubMed ID: 24080422
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma.
Chang KP; Lin SJ; Liu SC; Yi JS; Chien KY; Chi LM; Kao HK; Liang Y; Lin YT; Chang YS; Yu JS
Sci Rep; 2015 Jul; 5():11689. PubMed ID: 26138061
[TBL] [Abstract][Full Text] [Related]
3. Induction of chemokine (C-C motif) ligand 5 by Epstein-Barr virus infection enhances tumor angiogenesis in nasopharyngeal carcinoma.
Ma W; Feng L; Zhang S; Zhang H; Zhang X; Qi X; Zhang Y; Feng Q; Xiang T; Zeng YX
Cancer Sci; 2018 May; 109(5):1710-1722. PubMed ID: 29569795
[TBL] [Abstract][Full Text] [Related]
4. Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas.
Wu CC; Hsu CW; Chen CD; Yu CJ; Chang KP; Tai DI; Liu HP; Su WH; Chang YS; Yu JS
Mol Cell Proteomics; 2010 Jun; 9(6):1100-17. PubMed ID: 20124221
[TBL] [Abstract][Full Text] [Related]
5. Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population.
Mao MJ; Xue N; Wang XP; Chi PD; Liu YJ; Huang Q; Dai SQ; Liu WL
BMC Cancer; 2018 Jan; 18(1):9. PubMed ID: 29295705
[TBL] [Abstract][Full Text] [Related]
6. Proteome profiling of Epstein-Barr virus infected nasopharyngeal carcinoma cell line: identification of potential biomarkers by comparative iTRAQ-coupled 2D LC/MS-MS analysis.
Feng X; Zhang J; Chen WN; Ching CB
J Proteomics; 2011 Apr; 74(4):567-76. PubMed ID: 21296196
[TBL] [Abstract][Full Text] [Related]
7. Quantitative plasma proteome analysis reveals aberrant level of blood coagulation-related proteins in nasopharyngeal carcinoma.
Peng PH; Wu CC; Liu SC; Chang KP; Chen CD; Chang YT; Hsu CW; Chang YS; Yu JS
J Proteomics; 2011 May; 74(5):744-57. PubMed ID: 21376147
[TBL] [Abstract][Full Text] [Related]
8. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.
Chen Z; Long L; Wang K; Cui F; Zhu L; Tao Y; Wu Q; Xiang M; Liang Y; Qiu S; Xiao Z; Yi B
Oncotarget; 2016 Jun; 7(23):34022-37. PubMed ID: 27145374
[TBL] [Abstract][Full Text] [Related]
9. Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis.
Chang KP; Wu CC; Chen HC; Chen SJ; Peng PH; Tsang NM; Lee LY; Liu SC; Liang Y; Lee YS; Hao SP; Chang YS; Yu JS
Proteomics; 2010 Jul; 10(14):2644-60. PubMed ID: 20461718
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteome analysis of overexpressed Cripto-1 tumor cell reveals 14-3-3γ as a novel biomarker in nasopharyngeal carcinoma.
Wu Z; Weng D; Li G
J Proteomics; 2013 May; 83():26-36. PubMed ID: 23500129
[TBL] [Abstract][Full Text] [Related]
11. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
[TBL] [Abstract][Full Text] [Related]
12. Detection of nasopharyngeal carcinoma using surface-enhanced laser desorption and ionization mass spectrometry profiles of the serum proteome.
Cao SM; Yu JK; Chen QY; Li NW; Xiang YQ; Qian CN; Hu X; Zhang CQ; Xie D; Guo X
Chin J Cancer; 2010 Aug; 29(8):721-8. PubMed ID: 20663318
[TBL] [Abstract][Full Text] [Related]
13. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
[TBL] [Abstract][Full Text] [Related]
14. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM
Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781
[TBL] [Abstract][Full Text] [Related]
15. Circulating Epstein-Barr virus microRNA profile reveals novel biomarker for nasopharyngeal carcinoma diagnosis.
Wu L; Wang J; Zhu D; Zhang S; Zhou X; Zhu W; Zhu J; He X
Cancer Biomark; 2020; 27(3):365-375. PubMed ID: 31958073
[TBL] [Abstract][Full Text] [Related]
16. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
[TBL] [Abstract][Full Text] [Related]
17. High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma.
Coghill AE; Bu W; Nguyen H; Hsu WL; Yu KJ; Lou PJ; Wang CP; Chen CJ; Hildesheim A; Cohen JI
Clin Cancer Res; 2016 Jul; 22(14):3451-7. PubMed ID: 26920891
[TBL] [Abstract][Full Text] [Related]
18. Elevated blood levels of soluble tumor necrosis factor receptors in nasopharyngeal carcinoma: correlation with humoral immune response to lytic replication of Epstein-Barr virus.
Feng P; Chan SH; Ooi EE; Soo MY; Loh KS; Wang D; Ren EC; Hu H
Int J Oncol; 1999 Jul; 15(1):167-72. PubMed ID: 10375611
[TBL] [Abstract][Full Text] [Related]
19. Cell secretome analysis using hollow fiber culture system leads to the discovery of CLIC1 protein as a novel plasma marker for nasopharyngeal carcinoma.
Chang YH; Wu CC; Chang KP; Yu JS; Chang YC; Liao PC
J Proteome Res; 2009 Dec; 8(12):5465-74. PubMed ID: 19845400
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China.
Ji MF; Huang QH; Yu X; Liu Z; Li X; Zhang LF; Wang P; Xie SH; Rao HL; Fang F; Guo X; Liu Q; Hong MH; Ye W; Zeng YX; Cao SM
Cancer; 2014 May; 120(9):1353-60. PubMed ID: 24477877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
